Vivani Medical Stock (NASDAQ:VANI)

Ownership Financials Chart

Previous Close

$1.35

52W Range

$0.92 - $1.92

50D Avg

$1.18

200D Avg

$1.34

Market Cap

$82.12M

Avg Vol (3M)

$300.75K

Beta

3.37

Div Yield

-

VANI Company Profile

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

37

IPO Date

Nov 19, 2014

Website

VANI Performance

VANI Financial Summary

	Dec 25	Dec 24	Dec 23
Revenue	-	-	-
Operating Income	$-27.56M	$-24.68M	$-26.96M
Net Income	$-26.61M	$-23.49M	$-25.65M
EBITDA	$-27.56M	$-24.28M	$-25.30M
Basic EPS	$-0.43	$-0.43	$-0.50
Diluted EPS	$-0.43	$-0.43	$-0.50

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q4 19Mar 19, 20 | 4:30 PM

Q3 19Nov 15, 19 | 4:30 PM

Q2 19Aug 07, 19 | 4:30 PM

Peer Comparison

Ticker	Company
IMA	ImageneBio Inc
MBOT	Microbot Medical Inc.
QIPT	Quipt Home Medical Corp.
EDAP	Edap Tms S.a.
CRDL	Cardiol Therapeutics Inc.
NSPR	InspireMD, Inc.
ORMP	Oramed Pharmaceuticals Inc.
RCEL	AVITA Medical, Inc.
FONR	FONAR Corporation
HYPR	Hyperfine, Inc.